SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000893220-98-000018
Filing Date
1998-01-09
Accepted
1998-01-09 00:00:00
Documents
1
Group Members
SMITHKLINE BEECHAM PLCSR ONE LTD.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D FOR NPS PHARMACEUTICALS, INC. SC 13D 11037
  Complete submission text file 0000893220-98-000018.txt   13034
Mailing Address SMITHKLENE BEECHAM ONE FRANKLIN PLAZA PHILADELPHIA PA 19101
Business Address ONE NEW HORIZONS COURT BRENTFORD MIDDLESEX TW8 9EP ENGLAND X0
SMITHKLINE BEECHAM PLC (Filed by) CIK: 0000850695 (see all company filings)

IRS No.: 980101920 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 420 CHIPETA WAY SUITE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44877 | Film No.: 98504223
SIC: 2836 Biological Products, (No Diagnostic Substances)